Skip to main content
OpenTrials
Completed

NCT Number: NCT06515275

Video-Supported Medication Education for Women Undergoing In Vitro Fertilization (IVF): Quality of Life and Psychosocial Effects

Reproductive health problems, particularly infertility, affect 48 million couples globally, ranking as the fifth most serious global obstacle for women. Infertility can lead to significant psychosocial effects, including stress, anxiety, and depression, with women experiencing these impacts more severely than men. In vitro fertilization (IVF) offers a solution but comes with emotional, physical, and psychosocial challenges, particularly for women, who often experience fatigue, headaches, weight gain, and stress. Effective support mechanisms, such as information and education, are crucial in improving the IVF experience. Video-assisted educational programs have shown promise in enhancing knowledge and reducing stress during IVF treatment. However, there is a lack of studies evaluating their impact on the quality of life and psychosocial status of women undergoing IVF. This study aims to examine the effect of video-supported training on drug use, quality of life, and psychosocial status of women during IVF treatment, hypothesizing that it will improve quality of life, increase emotional capacity, and reduce anxiety.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–49 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Merve Coşkun

Ataşehir, Istanbul, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being female
  • Undergoing infertility treatment
  • Aged 18-49 years
  • Owning a tablet, smartphone, or similar device
  • Having internet access
  • Undergoing IVF treatment for the first time

Exclusion criteria

  • Previously received controlled ovarian stimulation treatment
  • Patients undergoing frozen embryo transfer
  • No internet access
  • Refusal to participate in the IVF medication teaching session

Treatment and study plan

Education via video (QR code links)

Other

Video education on self-administered medications for women undergoing IVF treatment

Primary outcomes

  1. Introductory Information Form

    Time frame: to both groups before the intervention

    A 28-question form designed by researchers to gather sociodemographic, general health, obstetric, and gynecological history of the participants.

  2. Screening Tool on Distress in Fertility Treatment's (SCREENIVF)

    Time frame: to both groups before the intervention and after oocyte aspiration (OPU)

    A tool recommended by ESHRE to assess psychosocial risk factors in individuals undergoing infertility treatment. The Turkish version consists of 28 items measuring anxiety, social support, helplessness, acceptance, and depression.

  3. Fertility quality of life tool (FertiQoL)

    Time frame: to both groups before the intervention and after oocyte aspiration (OPU)

    A 36-item scale developed by Boivin et al. (2011) to assess the quality of life in individuals with fertility problems. The Turkish version was validated by Dural et al. (2016).

  4. State-Trait Anxiety Inventory (STAI)

    Time frame: to both groups before the intervention and after oocyte aspiration (OPU)

    A 40-item inventory developed by Spielberger et al. (1970) and adapted to Turkish by Öner and Le Compte (1983). The inventory measures situational anxiety (20 items) and trait anxiety (20 items).

  5. Education Satisfaction Evaluation Form

    Time frame: to both groups after oocyte aspiration (OPU)

    A form developed by researchers to assess satisfaction with medication education. It uses a 0-10 scale, with higher scores indicating greater satisfaction. The form for the experimental group will also record video viewing behavior.

Sponsors and collaborators

Lead sponsor

Acibadem University

Other

Registry information

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jul 23, 2024
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.